These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12650497)

  • 21. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in plasma catecholamine concentrations and haemodynamic effects of rocuronium and vecuronium in elderly patients.
    Shorten GD; Uppington J; Comunale ME
    Eur J Anaesthesiol; 1998 May; 15(3):335-41. PubMed ID: 9649995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
    Bevan JC; Collins L; Fowler C; Kahwaji R; Rosen HD; Smith MF; de Scheepers LD; Stephenson CA; Bevan DR
    Anesth Analg; 1999 Aug; 89(2):333-9. PubMed ID: 10439743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.
    Lin PL; Liu CC; Fan SZ; Chao A; Shin SC; Tai YT
    Acta Anaesthesiol Sin; 1997 Sep; 35(3):127-31. PubMed ID: 9407675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of rocuronium bromide.
    Khuenl-Brady KS; Sparr H
    Clin Pharmacokinet; 1996 Sep; 31(3):174-83. PubMed ID: 8877248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
    Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
    Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia.
    Booth MG; Marsh B; Bryden FM; Robertson EN; Baird WL
    Anaesthesia; 1992 Oct; 47(10):832-4. PubMed ID: 1359803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of rocuronium and vecuronium pretreatment for prevention of fasciculations, myalgia and biochemical changes following succinylcholine administration.
    Kim JH; Cho H; Lee HW; Lim HJ; Chang SH; Yoon SM
    Acta Anaesthesiol Sin; 1999 Dec; 37(4):173-8. PubMed ID: 10670114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intubating conditions and onset of action after rocuronium, vecuronium, and atracurium in young children.
    Scheiber G; Ribeiro FC; Marichal A; Bredendiek M; Renzing K
    Anesth Analg; 1996 Aug; 83(2):320-4. PubMed ID: 8694312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracheal intubation conditions after one minute: rocuronium and vecuronium, alone and in combination.
    England AJ; Margarson MP; Feldman SA
    Anaesthesia; 1997 Apr; 52(4):336-40. PubMed ID: 9135185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction.
    Pedersen AF; Green S; Rose MA
    Anaesth Intensive Care; 2012 Nov; 40(6):1053-5. PubMed ID: 23194216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rocuronium bromide in dental day case anaesthesia--a comparison with atracurium and vecuronium.
    Chetty MS; Pollard BL; Wilson A; Healy TE
    Anaesth Intensive Care; 1996 Feb; 24(1):37-41. PubMed ID: 8669652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rocuronium onset of action: a comparison with atracurium and vecuronium.
    Bartkowski RR; Witkowski TA; Azad S; Lessin J; Marr A
    Anesth Analg; 1993 Sep; 77(3):574-8. PubMed ID: 8103649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rocuronium: high risk for anaphylaxis?
    Rose M; Fisher M
    Br J Anaesth; 2001 May; 86(5):678-82. PubMed ID: 11575345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pain during injection of rocuronium bromide.
    Lockey D; Coleman P
    Anaesthesia; 1995 May; 50(5):474. PubMed ID: 7793569
    [No Abstract]   [Full Text] [Related]  

  • 39. Sugammadex approved to reverse NMBA effects.
    Thompson CA
    Am J Health Syst Pharm; 2016 Feb; 73(3):100. PubMed ID: 26796899
    [No Abstract]   [Full Text] [Related]  

  • 40. Spontaneous movements associated with rocuronium: is pain on injection the cause?
    Borgeat A; Kwiatkowski D
    Br J Anaesth; 1997 Sep; 79(3):382-3. PubMed ID: 9389860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.